Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference
Main Authors: | Michael Gnant, Giuseppe Curigliano, Hansjörg Senn, Beat Thürlimann, Walter P. Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977622000637 |
Similar Items
-
Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021
by: Dario Trapani, et al.
Published: (2022-03-01) -
Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus
by: Hussein Khaled, et al.
Published: (2022-12-01) -
General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16<sup>th </sup>th International Breast Cancer Conference)
by: V. F. Semiglazov, et al.
Published: (2020-03-01) -
PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
by: Giuseppe Curigliano, et al.
Published: (2023-02-01) -
Hot Issues in Internal Medicine Treatment for HER2 Positive Early Breast Cancer Reflected in the 2019 St. Gallen International Breast Cancer Conference
by: ZHENG Yabing, et al.
Published: (2019-12-01)